This document aims to guide Environmental Health Services (EHS) on key roles related to the management of the outbreak.
This guide should be read in conjunction with the guideline for case finding, diagnosis, management and public health response in South africa and the standard operating procedur...es on Novel Corona Virus -19 (COVID-19).
more
1. What is COVID-19?
2. Who is at most risk for COVID-19?
3. What is the risk of COVID-19 infection in humans in South Africa?
4. How is COVID-19 transmitted?
5. What are the signs and symptoms of COVID-19 infection in humans?
6. How is COVID-19 diagnosed?
7. How is COVID-19 infection ...treated?
8. How can COVID-19 infection in humans be prevented?
9. What measures have been put in place in South Africa to minimise the risk of transmission should cases be imported?
10. Should I travel now?
11. Who can I contact for more information?
more
Timely detection of novel coronavirus (2019-nCoV) infection cases is crucial to interrupt the spread of this virus. We assessed the required expertise and capacity for molecular detection of 2019-nCoV in specialised laboratories in 30 European Union/European Economic Area (EU/EEA) countries. Thirty-...eight laboratories in 24 EU/EEA countries had diagnostic tests available by 29 January 2020. A coverage of all EU/EEA countries was expected by mid-February. Availability of primers/probes, positive controls and personnel were main implementation barriers.
more
L’exercice COVID-19 de Table Top (TTX) est un outil qui a été développé pour aider les gouvernements et les organismes à renforcer les plans et les politiques dans le but d’identifier, de contenir l’apparation de cas de COVID-19 dans le pays. La simulation TTX est conçue pour soutenir l...utilisation de la « liste des repères de préparation opérationnelle pour COVID-19» (voir dans les documents de référence fournis). Cet exercice utilise un scénario commençant avec un cas importé, comme base pour une discussion détaillée guidée par le facilitateur de l’exercice.
more
L'exercice de table COVID-19 (TTX) est un package de simulation qui utilise un scénario progressif ainsi qu'une série d'injects spécifiques pour permettre aux participants de considérer l'impact potentiel d'une épidémie sur les plans, procédures et capacités existants. Le TTX a pour objectif... de renforcer les niveaux nationaux de préparation au coronavirus grâce à une série de discussions de groupe facilitées.
more
Évaluation des participants| COVID-19 TTX
Vos commentaires nous aideront à maintenir et à améliorer la qualité et la pertinence des futurs exercices de simulation.
Participants’ Evaluation | COVID-19 TTX
Your feedback will assist us to maintain and improve the quality and relevance of future simulation exercises.
The Table Top (TTX) COVID-19 exercise is a tool that has been developed to assist Governments and Agencies in the process of strengthening plans and policies with the intention of being able to identify and contain and outbreak of COVID19 in the country. The TTX Simulation is designed to support the... use of the “WHO Operational Readiness Benchmarks for COVID-19” (see in reference documents provided). This exercise uses the scenario of an imported case, as the base for a detailed discussion guided by the exercise facilitator.
more
General Objectives
1. Share information on practices on IPC for endemic colonization in a tertiary facility and how those precautions could evolve based on the progress of the event, then further integrating response capabilities, plans and procedures to triage and implement source control measure...s for case of COVID-19 in your facility.
2. Identify challenges in bed occupancy and staff management between different departments.
3. Conduct gap analysis through reflection on how the scenario could play out in your countries.
4. Identify areas for action in your facilities based on the issues explored in the scenario.
more
Общие цели
1. Распространить информацию о ходе подготовки, в том числе о потенциале в области реагирования и планах и процедурах реагирования в целях выявления за...озных случаев COVID-19 в вашей стране и принятия ответных мер.
2. Определить сферы взаимозависимости субъектов сектора здравоохранения и других секторов.
3. Провести анализ недостатков с опорой на предложенные ВОЗ сравнительные показатели оперативной готовности к COVID-19.
4. Разработать план действий по повышению уровня готовности на основании сравнительных показателей ВОЗ.
more
Objectifs généraux
1. Partager des informations sur l'avancement de la préparation, y compris les capacités de réponse, les plans et les procédures pour identifier et répondre à des cas de COVID-19 dans votre pays.
2. Identifier les domaines d'interdépendance entre les acteurs de la san...té et d'autres secteurs
3. Mener une analyse des lacunes sur la base du Plan stratégique de préparation et de réponse COVID-19
4. Élaborer un plan d'action pour améliorer votre niveau de préparation, basé sur la liste de contrôle de l'OMS.
more
Qualitative assay for use on the cobas®6800/8800 Systems. For in vitro diagnostic use
The virtual conference, co-organised by the Africa Centres for Disease Control and Prevention (Africa CDC) and the South African Medical Research Council (SAMRC) brought together African leaders, public health professionals and researchers, policymakers, business leaders and civil society and commun...ity leaders.
The objective was to discuss strategies and approaches to remove barriers to widespread delivery and uptake of effective COVID-19 vaccines across Africa, guided by African voices and indigenous values. The goal of the conference was to provide input for a framework for fair, equitable and timely allocation of COVID-19 vaccines in Africa.
more
Обновление рекомендаций по санитарно-эпидемиологическому надзору за COVID-19 от
16 декабря 2020 г
Обновленная версия. В этой версии приведены обновленные рекомендации относительно стратегии диагностического тестирования в контексте обновлённой классификаци...и способов передачи, мер общественного здравоохранения и социальных мер, эпиднадзора за общественным здравоохранением и установленных ВОЗ определений случая COVID-19. В данном руководстве учтено использование новых инструментов, таких, как диагностические экспресс-тесты для выявления антигенов (ДЭТ-АГ) и аспекты тестирования привитых лиц, а также тестирования на генетические мутации, связанные с вариантами. Кроме того, для этой версии разработаны приложения, включая подборку полезных ресурсов и десять компонентов расширения тестирования на субнациональном уровне.
more
The crisis caused by the COVID-19 pandemic exacerbated preexisting structural economic inequalities, and had a disproportionate impact on informal workers, especially on women and young people, who lost jobs and income. The situation was even more difficult for single-parent households led by women,... who also had to endure more housework and care tasks. As shown by various research studies, the asymmetric distribution of care tasks, taken up by women, is an inequality factor.
more
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for hospital admission in patients with non-severe COVID-19
The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19.
The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients.
This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines:
**High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%.
**Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%.
Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk.
Review of COVID-19 treatments for people with non-severe COVID-19
WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022.
If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead.
WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission.
For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol.
WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials.
The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials.
more